Novonix (NVX) Shares Outstanding (Weighted Average) (2020 - 2025)

Novonix (NVX) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $485.5 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 32.09% year-over-year to $485.5 million; the trailing twelve-month figure through Dec 2025 stood at $485.5 million (up 32.09% YoY), and the FY2025 full-year result was $485.5 million, up 32.09% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $485.5 million, up from $367.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $485.5 million in Q4 2025 and bottomed at $282.1 million in Q2 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $338.3 million (2022), against an average of $357.4 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) surged 293.1%; it then climbed 0.09% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $282.1 million in 2021, then climbed by 19.87% to $338.1 million in 2022, then rose by 0.09% to $338.4 million in 2023, then gained by 8.6% to $367.5 million in 2024, then surged by 32.09% to $485.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $485.5 million (Q4 2025), $367.5 million (Q4 2024), and $338.4 million (Q4 2023), per Business Quant data.

Peer Comparison